论文部分内容阅读
目的:观察分析阿伦磷酸钠与钙尔奇联合应用对于糖尿病合并骨质疏松症治疗的效果。方法:2013年3月-2014年3月于我院住院收治的糖尿病合并骨质疏松症患者60例,随机分为阿伦磷酸钠联合组(30例)和钙尔奇组(30例),观察分析阿伦磷酸钠联合组与钙尔奇组治疗前后疼痛评分(VAS评分)、腰椎及股骨骨密度值。结果:阿伦磷酸钠联合组治疗后3个月和治疗后6个月的VAS评分均显著低于钙尔奇组(p<0.05);阿伦磷酸钠联合的L3、L4、股骨颈和股骨粗隆的骨密度均显著高于钙尔奇组(p<0.05)。结论:阿伦磷酸钠和钙尔奇D能够有效地治疗糖尿病合并骨质疏松。
OBJECTIVE: To observe and analyze the effect of combination of alendronate and calcic on the treatment of diabetic patients with osteoporosis. Methods: From March 2013 to March 2014, 60 patients with diabetes mellitus and osteoporosis hospitalized in our hospital were randomly divided into Aalpine sodium phosphate combined group (30 cases) and Calcium group (30 cases) The analgesic scores (VAS score), the lumbar vertebral and femur BMD scores before and after treatment were observed and analyzed in the combination of alendronate sodium and calcium group. Results: VAS scores at 3 months and 6 months after treatment in alendronate sodium group were significantly lower than those in the calcium group (p <0.05); alendronate combined with L3, L4, femoral neck and femur The trochanter bone mineral density was significantly higher than that of the golchet group (p <0.05). Conclusion: Allergy sodium phosphate and Calcium D can effectively treat diabetic patients with osteoporosis.